AIT Bioscience Among Inc.’s 5000 Fastest Growing Private Companies

August 17, 2017

Indianapolis, IN August 16, 2017 – Inc. magazine today ranked AIT Bioscience NO. 2366 on its 36th annual Inc. 5000, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment— its independent small and midsized businesses. Well-known names including Microsoft, Dell and LinkedIn gained their first national exposure as honorees of the Inc. 5000.

AIT Bioscience is No. 18 of Indianapolis metropolitan companies and is the highest ranked of any bioanalytical laboratory on this list. The company first appeared on this list in 2015 ranking No. 179.

“Of the tens of thousands of companies that have applied to the Inc. 5000 over the years, only a fraction have made the list more than once,” said Eric Schurenberg, President and Editor in Chief of Inc. Media. “A mere one in three have made the list two times.”

The 2017 Inc. 5000, unveiled online at Inc.com,. is the most competitive crop in the list’s history. The average company on the list achieved a mind-boggling three-year average growth of 481%. The Inc. 5000’s aggregate revenue is $206 billion, and the companies on the list collectively generated 619,500 jobs over the past three years. Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at www.inc.com/inc5000.

About AIT Bioscience

AIT Bioscience, LLC, headquartered in Indianapolis, Indiana, is an integrated contract research laboratory (CRO) supported by a state-of-the-art, smart, electronic laboratory environment. This allows AIT Bioscience to devise the best solution for its clients, across each of its bioanalytical service areas. AIT Bioscience delivers robust analytical methods, highly-skilled and experienced client consultation, efficient sample logistics and rapid sample analysis from pre-IND through investigational new drug (IND), new drug application (NDA), abbreviated new drug application (ANDA) and Biologics License Application (BLA). For more information, visit www.aitbioscience.com.

For more information contact:

Terri Pascarelli
Chief Executive Officer
AIT Bioscience
317-715-8809
tpascarelli@aitbioscience.com

More about Inc. and the Inc. 5000

Methodology

The 2017 Inc. 5000 is ranked according to percentage revenue growth when comparing 2013 to 2016. To qualify, companies must have been founded and generating revenue by March 31, 2013. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2016. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2013 is $100,000; the minimum for 2016 is $2 million.

About Inc. Media:

Founded in 1979 and acquired in 2005 by Mansueto Ventures, Inc. is the only major brand dedicated exclusively to owners and managers of growing private companies, with the aim to deliver real solutions for today’s innovative company builders. Winner of the National Magazine Award for General Excellence in both 2014 and 2012. Total monthly audience reach for the brand has grown significantly from 2,000,000 in 2010 to over 18,000,000 today. For more information, visit www.inc.com.

The Inc. 5000 is a list of the fastest-growing private companies in the nation. Started in 1982, this prestigious list of the nation’s most successful private companies has become the hallmark of entrepreneurial success.

For more information contact:

Inc. Media
Drew Kerr
212-849-8250
drew@four-corners.com